MARIPOSA THERAPEUTICS LIMITED

12373627
Active Cardiff

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MARIPOSA THERAPEUTICS LIMITED

12373627

Research and experimental development on biotechnology

Founded 20 Dec 2019 Active Cardiff, Wales 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 29 Jan 2026 Next due 12 Feb 2027 8 months remaining
Net assets £1M £142K 2024 year on year
Total assets £2M £129K 2024 year on year
Total Liabilities £297K £13K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

International House 10 Churchill Way Cardiff CF10 2HE Wales

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MARIPOSA THERAPEUTICS LIMITED (12373627), an active life sciences and medical technology company based in Cardiff, Wales. Incorporated 20 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£3.81k

Decreased by £2.75k (-42%)

Net Assets

£1.46M

Decreased by £141.88k (-9%)

Total Liabilities

£297.50k

Increased by £13.11k (+5%)

Turnover

N/A

Employees

4

Debt Ratio

17%

Increased by 2 (+13%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Aug 2020Pre-Seed
Investor 2Aug 2020Pre-Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 587,409 Shares £622.72m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Jan 2025179,871£2k£0.01
25 Jul 2022407,538£622.72m£2k

Officers

Officers

3 active
Status
Catharina Hendrika Gezina Maria BeumerDirectorDutchUnited Kingdom6620 Dec 2019Active
Damian John MarronDirectorBritish,irishFrance6315 Jun 2022Active
Thomas Christian HafnerDirectorGermanUnited Kingdom6220 Dec 2019Active

Shareholders

Shareholders (9)

Timothy Hafner
42.2%
1,129,450
Lucas Hafner
42.2%
1,129,450

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Mr Timothy Calvin Hafner

Dutch

Active
Notified 29 Jan 2026
Residence Malta
DOB February 1999
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr Lucas Maximilian Hafner

Dutch

Active
Notified 29 Jan 2026
Residence Malta
DOB January 2001
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Ctl Familienstiftung

Unknown

Active
Notified 28 Jul 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent As Trust,voting Rights 75 To 100 Percent As Trust,right To Appoint And Remove Directors As Trust

Neem Biotech Limited

Ceased 28 Jul 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Jan 2026Persons With Significant ControlTimothy Calvin Hafner notified as a person with significant control
29 Jan 2026Persons With Significant ControlLucas Maximilian Hafner notified as a person with significant control
29 Jan 2026Confirmation StatementConfirmation statement made on 29 Jan 2026 with updates
29 Jan 2026Persons With Significant ControlCessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026
26 Sept 2025OfficersChange to director Catharina Hendrika Gezina Maria Beumer on 1 Sept 2025
29 Jan 2026 Persons With Significant Control

Timothy Calvin Hafner notified as a person with significant control

29 Jan 2026 Persons With Significant Control

Lucas Maximilian Hafner notified as a person with significant control

29 Jan 2026 Confirmation Statement

Confirmation statement made on 29 Jan 2026 with updates

29 Jan 2026 Persons With Significant Control

Cessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026

26 Sept 2025 Officers

Change to director Catharina Hendrika Gezina Maria Beumer on 1 Sept 2025

Recent Activity

Latest Activity

Timothy Calvin Hafner notified as a person with significant control

4 months ago on 29 Jan 2026

Lucas Maximilian Hafner notified as a person with significant control

4 months ago on 29 Jan 2026

Confirmation statement made on 29 Jan 2026 with updates

4 months ago on 29 Jan 2026

Cessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026

4 months ago on 29 Jan 2026

Change to director Catharina Hendrika Gezina Maria Beumer on 1 Sept 2025

8 months ago on 26 Sept 2025